TY  - JOUR 
AU  - Martínez-Pinilla, Eva
AU  - Aguinaga, David
AU  - Navarro, Gemma
AU  - Rico, Alberto J.
AU  - Oyarzabal, Julen
AU  - Sánchez-Arias, Juan Antonio
AU  - Lanciego, Jose L.
AU  - Franco, Rafael
PY  - 2019
SN  - 0893-7648
UR  - http://hdl.handle.net/20.500.12020/1549
AB  - Cannabinoid CB1 receptors (CB1R) and the GPR55 receptor are expressed in striatum and are potential targets in the therapy of Parkinson's disease (PD), one of the most prevalent neurodegenerative diseases in developed countries. The aim of this paper...
LA  - en
PB  - Springer
TI  - Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson's Disease
DO  - https://doi.org/10.1007/s12035-019-1495-4
T2  - Molecular Neurobiology
M2  - 5900
KW  - Cannabinoid Receptors
KW  - GPCRs
KW  - Neurodegenerative Diseases
KW  - Neuroprotection
KW  - MPP+
VL  - 56
ER  -